ASGCT Guide Modification Poster

May

5

Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May

Apr

28

Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

Mar

20

Editas Medicine Announces Chief Financial Officer Transition